GlaxoSmithKline PLC ADR (GSK) — Cash Flow Quality Index
GlaxoSmithKline PLC ADR (GSK) has a Cash Flow Quality Index of 0.62x as of March 2026. Operating cash flow of $1.14 Billion is below net income of $1.84 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of GlaxoSmithKline PLC ADR to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GlaxoSmithKline PLC ADR Cash Flow Quality Index (1990–2025)
Historical Cash Flow Quality Index for GlaxoSmithKline PLC ADR across 36 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GlaxoSmithKline PLC ADR investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year earnings quality comparison for GlaxoSmithKline PLC ADR. For live market cap and the full company financial profile, see GlaxoSmithKline PLC ADR market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.28x | $7.14 Billion | $5.59 Billion | ▼ -42.5% |
| 2024 | 2.22x | $6.55 Billion | $2.95 Billion | ▲ +72.4% |
| 2023 | 1.29x | $7.89 Billion | $6.13 Billion | ▼ -14.4% |
| 2022 | 1.50x | $7.40 Billion | $4.92 Billion | ▼ -3.6% |
| 2021 | 1.56x | $7.95 Billion | $5.10 Billion | ▲ +18.1% |
| 2020 | 1.32x | $8.44 Billion | $6.39 Billion | ▼ -13.2% |
| 2019 | 1.52x | $8.02 Billion | $5.27 Billion | ▼ -26.9% |
| 2018 | 2.08x | $8.42 Billion | $4.05 Billion | ▼ -34.7% |
| 2017 | 3.19x | $6.92 Billion | $2.17 Billion | ▼ -47.9% |
| 2016 | 6.12x | $6.50 Billion | $1.06 Billion | ▲ +1893.7% |
| 2015 | 0.31x | $2.57 Billion | $8.37 Billion | ▼ -83.2% |
| 2014 | 1.83x | $5.18 Billion | $2.83 Billion | ▲ +42.5% |
| 2013 | 1.28x | $7.22 Billion | $5.63 Billion | ▲ +39.1% |
| 2012 | 0.92x | $4.38 Billion | $4.74 Billion | ▼ -19.5% |
| 2011 | 1.15x | $6.25 Billion | $5.46 Billion | ▼ -68.8% |
| 2010 | 3.67x | $6.80 Billion | $1.85 Billion | ▲ +165.2% |
| 2009 | 1.38x | $7.84 Billion | $5.67 Billion | ▼ -10.9% |
| 2008 | 1.55x | $7.31 Billion | $4.71 Billion | ▲ +103.3% |
| 2007 | 0.76x | $5.79 Billion | $7.59 Billion | ▲ +50.6% |
| 2006 | 0.51x | $3.96 Billion | $7.81 Billion | ▼ -37.6% |
| 2005 | 0.81x | $5.59 Billion | $6.87 Billion | ▼ -1.9% |
| 2004 | 0.83x | $4.77 Billion | $5.76 Billion | ▲ +8.8% |
| 2003 | 0.76x | $4.85 Billion | $6.38 Billion | ▲ +38.0% |
| 2002 | 0.55x | $3.06 Billion | $5.55 Billion | ▼ -43.3% |
| 2001 | 0.97x | $4.61 Billion | $4.74 Billion | ▲ +148.0% |
| 2000 | 0.39x | $1.85 Billion | $4.73 Billion | ▲ +101.6% |
| 1999 | 0.19x | $510.00 Million | $2.62 Billion | ▲ +27.1% |
| 1998 | 0.15x | $410.00 Million | $2.68 Billion | ▼ -29.9% |
| 1997 | 0.22x | $615.00 Million | $2.82 Billion | ▼ -19.6% |
| 1996 | 0.27x | $849.00 Million | $3.13 Billion | ▼ -48.4% |
| 1995 | 0.53x | $1.25 Billion | $2.38 Billion | ▼ -77.7% |
| 1994 | 2.36x | $2.45 Billion | $1.04 Billion | ▲ +306.6% |
| 1993 | 0.58x | $1.05 Billion | $1.82 Billion | ▼ -4.7% |
| 1992 | 0.61x | $927.00 Million | $1.52 Billion | ▲ +19.1% |
| 1991 | 0.51x | $657.00 Million | $1.29 Billion | ▼ -8.4% |
| 1990 | 0.56x | $615.00 Million | $1.10 Billion | — |